Cell Cycle |
Entry into G2 phase |
2.86 × 10−2
|
EGR1, RUNX2
|
Cellular Growth and Proliferation, Embryonic Development |
Formation of embryonic cells |
2.86 × 10−2
|
GNAO1, RUNX2
|
Gene Expression |
Transcription of DNA |
2.86 × 10−2
|
BEX1, EGR1, FZD5, GTF3C6, HEXIM2, HMGA1, RUNX2, TARBP1, ZFP36L2, ZNF628, ZNF703
|
Cancer, Organismal Injury and Abnormalities |
Epithelial cancer |
2.86 × 10−2
|
BEX1, C9orf172, CDKL4, CHD9, CHSY3, CLEC16A, CPEB2, CTNNAL1, DDIT4, DENND4C, DMBT1, EGR1, FZD5, GNAO1, GTF3C6, HEXIM2, HMGA1, INPP5J, KIAA1217, NWD2, PRR12, RUNX2, SEMA6A, SLC25A36, SMG7, SUSD6, TARBP1, WDR76, ZFP36L2, ZNF628, ZNF703
|
Cellular Development, Hematological System Development and Function, Hematopoiesis |
Erythropoiesis of cells |
2.86 × 10−2
|
EGR1, HMGA1 |
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease |
Mammary tumor |
2.86 × 10−2
|
BEX1, CPEB2, CTNNAL1, DDIT4, EGR1, GNAO1, INPP5J, RUNX2, SUSD6, ZFP36L2, ZNF703
|
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development |
Differentiation of T-lymphocytes |
2.86 × 10−2
|
EGR1, FZD5, HMGA1, RUNX2, ZFP36L2
|
Cellular Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development |
Development of lymphocytes |
|
EGR1, Fus, FZD5, HMGA1, RUNX2, ZFP36L2
|
Endocrine System Development and Function, Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry |
Secretion of aldosterone |
|
EGR1, HMGA1 |